Killing bacteria softly in the cerebrospinal fluid may be advantageous in bacterial meningitis

Critical Care Medicine

Volumn 37, Issue 7, 2009, Pages 2317-2318

  Schønheyder, Henrik C ^a   Østergaard, Christian ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Central nervous system bacterial infections; Inflammation; Meningitis; Rifampicin; Streptococcus pneumoniae; Therapy

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CLINDAMYCIN; DEXAMETHASONE; GLUCOCORTICOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PENICILLIN G; PNEUMOCOCCUS VACCINE; RIFAMPICIN; ANTIINFECTIVE AGENT;

ADJUVANT THERAPY; ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; BACTERICIDAL ACTIVITY; CEREBROSPINAL FLUID; EDITORIAL; GROUP A STREPTOCOCCAL INFECTION; HAEMOPHILUS MENINGITIS; HUMAN; IMMUNIZATION; INTENSIVE CARE; MENINGOCOCCOSIS; NONHUMAN; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; TOXIC SHOCK SYNDROME; TREATMENT OUTCOME; ANIMAL; DRUG ADMINISTRATION; DRUG COMBINATION; NOTE; PATHOPHYSIOLOGY; RABBIT;

ANIMALS; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; MENINGITIS, PNEUMOCOCCAL; RABBITS; RIFAMPIN;

EID: 67649783364     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181a9f752     Document Type: Editorial

References (21)

1. Hsu HE, Shutt KA, Moore MR, et al: Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009; 360:244-256
2. Ninis N, Phillips C, Baily L, et al: The role of healthcare delivery in the outcome of meningococcal disease in children: Case-control study of fatal and non-fatal cases. BMJ 2005; 330:1475
3. Proulx N, Fréchette D, Toye B, et al: Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 2005; 98:291-298
4. Hahné SJM, Charlett A, Purcell B, et al: Effectiveness of antibiotics given before admission in reducing mortality from meningococcal disease: Systematic review. BMJ 2006; 332:1299-1303
5. Sørensen HT, Nielsen GL, Schønheyder HC, et al: Outcome of pre-hospital antibiotic treatment of meningococcal disease. J Clin Epidemiol 1998; 51:717-721
6. Harnden A, Ninis S, Thompson M: Parenteral penicillin for children with meningococcal disease before hospital admission: Casecontrol study. BMJ 2006; 332:1295-1298
7. van de Beek D, de Gans J, McIntyre P, et al: Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007; CD004405
8. Molyneux EM, Walsh AL, Forsyth H, et al: Dexamethasone treatment in childhood bacterial meningitis in Malawi: A randomised controlled trial. Lancet 2002; 360:211-218
9. de Gans J, van de Beek D: Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347:1549-1556
10. Nguyen TH, Tran TH, Thwaites G, et al: Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 2007; 357:2431-2440
11. Scarborough M, Gordon SB, Whitty CJ, et al: Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007; 357:2441-2450
12. van de Beek D, de Gans J: Dexamethasone and pneumococcal meningitis. Ann Intern Med 2004; 141:327
13. Weisfelt M, van de Beek D, de Haan RJ, et al: Dexamethasone and prognostic factors in adults with bacterial meningitis. J Neurol 2005; 253:570-573
14. Leib SL, Heimgartner C, Bifrare YD, et al: Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr Res 2003; 54:353-357
15. Zysk G, Brück W, Gerber J, et al: Antiinflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol 1996; 55:722-728
16. Weisfelt M, Hoogman M, van de Beek D, et al: Dexamethasone and long-term outcome in adults with bacterial meningitis. Ann Neurol 2006; 60:456-468
17. Spreer A, Lugert R, Stoltefaut V, et al: Shortterm rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis. Crit Care Med 2009; 37:2253-2258
18. Heer C, Stuertz K, Reinert R, et al: Release of teichoic and lipoteichoic acids from 30 different strains of Streptococcus pneumoniae during exposure to ceftriaxone, meropenem, quinupristin/dalfopristin, rifampicin and trovafloxacin. Infection 2000; 28:13-20
19. Böttcher T, Gerber J, Wellmer A, et al: Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis. J Infect Dis 2000; 181:2095-2098
20. Gerber J, Pohl K, Sander V, et al: Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone. Antimicrob Agents Chemother 2003; 47:1313-1317
21. Nau R, Wellmer A, Soto A, et al: Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J Infect Dis 1999; 79:1557-1560